DowAgrosciences cultivates sales record, but profit withers
Despite a boost in third-quarter revenue due to crop-protection products, profit for the local unit of Dow Chemical tumbled more than 71 percent.
Life Science & Biotech
Articles
State medical institute snares $30M grant from feds
A consortium of Indiana University, Purdue University and University of Notre Dame can operate for another five years with the grant funds.
Is lack of competition hiking Indiana exchange premiums?
Only four health insurers are offering policies in the Obamacare exchange in Indiana, whereas 17 have withdrawn from the market since 2010.
Republicans making same old mistake on health reform
Rather than railing incessantly against Obamacare, Republicans would do themselves and the country a favor if they finally agreed on a common alternative for fixing the health care system.
Analysts: Investors wrong to dump Endocyte
Investors on Friday dumped shares of West Lafayette-based Endocyte Inc. after an independent analysis said an experimental lung cancer drug is unlikely to be declared superior to existing chemotherapy. But two analysts say, to the contrary, the analysis shows the prospects for Endocyte’s drug are as good as ever.
Finding where the money is in health care
More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.
Shift from information scarcity to abundance will transform health care
With payment reform and new technology, it’s plausible that health care will shift from being a bricks and mortar business to an information business–bringing us higher quality and lower costs. That’s exciting.
Lilly scientists stole $55 million in trade secrets, indictment alleges
Three former employees of Eli Lilly and Co. allegedly transferred trade secrets that Lilly values at more than $55 million to a competing Chinese drug company, according to an indictment unsealed Tuesday in federal court.
Dow Agro wins latest patent case involving Enlist product
The suit, filed in January 2012 by South African-based Bayer CropScience SA, charged that Dow Agro’s Enlist E3 soybean seed infringed one of its patents.
Overbuilt, overstaffed, top heavy, hospitals ripe for cuts
Before this year’s cuts, Indiana hospitals had added 12,000 jobs over the past six years, even as private employers across Indiana, collectively, added no net new workers.
Technology on track to dramatically change health care
Cost pressures are forcing health care providers to extend the reach of limited resources.
Pence pleads for end to medical device tax
Republican Gov. Mike Pence wrote a letter Monday urging members of the U.S. Senate to vote to repeal the medical device tax that is helping to finance Obamacare. But the Senate on Monday night voted not to repeal the tax, with all 54 Democrats voting to keep it.
Want health reform? Change these 6 things all at once
Meaningful health reform has proved so difficult because it requires simultaneous change across a massive system. Here’s a post-Obamacare plan to do exactly that.
Auction lands $2.1 million for Elona Biotech assets
Elona went into receivership in June after Greenwood officials filed a foreclosure lawsuit against the firm. The company failed after receiving more than $8 million in economic development incentives from the city over the past three years.
Device prices plunge as hospitals pay less to fix hearts, hips
Prices paid in the United States for medical devices, including those made by Indiana-based manufacturers, have plunged as much as one-third since 2007 as hospitals clamped down on spending.
Hey IU, someone has to pay for those health care jobs
The IU researchers, as have many before them, approach health care jobs as if every one of them is an unmixed blessing to the Indiana economy. Employers and workers could have easily told them that’s not the case.
Top 10 blogs for the business of health care
I follow these blogs to keep up on health care financing. Tell me what else I should be reading.
Doctors, as well as patients, in the dark about prices
If you’re frustrated that health care prices are both unavailable and incomprehensible, you’re not alone. Your physician is in the dark too.
Hospitals aren’t bad guys; they’re just business guys
Even in the face of alarmingly high hospital prices, no one should conclude that hospitals are the bad guys in the health care system. Hospital executives are doing exactly what they’re supposed to be doing as the business leaders of their institutions.
After years of success, Harlan Laboratories caught in debt vise
The company may violate loan covenants in the next three to six months, and its ability to refinance a $280 million loan that matures in July 2014 is “highly questionable,” Moody’s says.